Study results from Vertex, Alnylam and Roche could either speed or stall biotech’s recent momentum.Two years into a drawn-out downturn, the biotechnology sector finally got news that might buoy its fortunes.In December, the Federal Reserve signaled plans to cut interest rates next year, accelerating a market run that has helped biotechs’s two main stock indexes […]
